Aligning Science Across Parkinson's Logo Text

Uncovering the Roots of Parkinson’s Disease

Aligning Science Across Parkinson’s (ASAP) is a global research initiative changing the way science is typically done. By emphasizing collaboration, generation of research-enabling resources, and data sharing, we are accelerating the pace of discovery for Parkinson’s disease research.

Our Goal

Parkinson’s is the world’s second most common neurodegenerative disease and fastest-growing in prevalence. Parkinson's has no cure and no proven disease-modifying treatments that can prevent or slow the underlying neurodegeneration.

We are building collaborative and transparent research processes in an environment that can deliver faster and better research outcomes for Parkinson’s disease.

Our Method
  • Funnel new ideas into the Parkinson’s disease research and development pipeline
  • Facilitate the rapid exchange of scientific ideas
  • Ensure that ASAP-funded work can be leveraged by others
  • Establish a strong, diverse, and global pipeline of the next generation of Parkinson’s disease researchers

Our Research Community

Our global initiative was designed to break down silos and encourage scientific interactions. We currently support three programs, each with the goal of advancing research for the benefit of the entire Parkinson's community.

As a committed member of several consortia, we work collectively with organizations and the research community to accelerate scientific advances by fostering a collaborative and open approach to research.

ASAP By the Numbers

These figures reflect the growing momentum behind our mission to accelerate the pace of discovery for Parkinson's through collaboration and open science.

+ 0
Research outputs generated by ASAP-funded researchers

Our Catalog showcases articles, code, datasets, lab materials, and protocols developed by our grantees.

Access Catalog
+ 0
Investigators leading research in the Collaborative Research Network

CRN investigators lead multi-disciplinary teams to address high-priority questions in Parkinson’s disease research.

Learn More
+ 0
Research cohorts in the Global Parkinson’s Genetics Program

Cohorts from around the world contribute data and samples for GP2 processing and analysis.

Learn More
+ 0
Participants in the Parkinson’s Progression Markers Initiative (PPMI) clinical cohorts

PPMI collaborates with partners around the world to create a robust open-access dataset and biosample library.

Learn More
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.